P. Tyle

发表

Diagnostics in the Year 2000: Antibody, Biosensor, and Nucleic Acid Technologies

Prithipal Singh, B. P. Sharma, P. Tyle, 1993 .

Biochemical Mechanisms of Platinum Antitumor Drugs

P. Tyle, B. P. Ram, 1987 .

Drug Delivery by Phonophoresis

P. Tyle, P. Agrawala, 1989, Pharmaceutical Research.

Immunoconjugates: Applications in Targeted Drug Delivery for Cancer Therapy

P. Tyle, B. P. Ram, 1987, Pharmaceutical Research.

Immunogenetics of the major histocompatibility complex.

R. Srivastava, P. Tyle, B. P. Ram, 1991 .

Guidelines for Selecting Sustained-Release Technology

P. Tyle, L. Pavliv, Georgette Chen, 2000 .

Determination of absorption characteristics of AG337, a novel thymidylate synthase inhibitor, using a perfused rat intestinal model.

S. Roy, P. Tyle, Y. Li, 1998, Journal of pharmaceutical sciences.

A Cubic-Phase Oral Drug Delivery System for Controlled Release of AG337

M. Longer, P. Tyle, J. Mauger, 1996 .

Drug delivery devices : fundamentals and applications

P. Tyle, 1988 .

Solid-state characterization of AG337 (Thymitaq), a novel antitumor drug.

A. Dash, P. Tyle, 1996, Journal of pharmaceutical sciences.

Controlled drug delivery: Fundamentals and applications

P. Tyle, 1988 .

Pharmaceutical Development of Suspension Dosage Form

Y. Ali, P. Tyle, Akio Kimura, 2010 .

Preformulation studies for the development of a parenteral liquid formulation of an antitumor agent, AG337.

S. Li, P. Tyle, Saumendu Deb Roy, 1997, PDA journal of pharmaceutical science and technology.

Effect of size, shape and hardness of particles in suspension on oral texture and palatability.

P. Tyle, 1993, Acta psychologica.

Spontaneous formation of drug-containing acrylic nanoparticles.

R. Bodmeier, R Bodmeier, H Chen, 1991, Journal of microencapsulation.

Effect of Size, Shape and Hardness of Particles in Suspension on Oral Palatability

P. Tyle, P. Jarosz, Cary K Kuenn, 1990 .

Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form

R. Bodmeier, P. Tyle, P. Jarosz, 1991 .

Preformulation studies of a novel HIV protease inhibitor, AG1343.

M. Longer, P. Tyle, B. Shetty, 1995, Journal of pharmaceutical sciences.

Phytosterol Stabilized Emulsions: Interpacial Complexation and Structural Investigations

S. G. Frank, P. Tyle, 1990 .

Diagnostics—Where We Were, Where We Are, and Where We are Going: An Introduction

Prithipal Singh, Praveen Tyle, Bhanu P. Sharma, 1993 .

Targeted therapeutic systems

P. Tyle, B. P. Ram, 1990 .

Solid-state phase transitions of AG337, an antitumor agent.

R. Suryanarayanan, P. Tyle, Saumendu Deb Roy, 1999, Pharmaceutical development and technology.

Monoclonal antibodies, immunoconjugates, and liposomes as targeted therapeutic systems.

P. Tyle, B. P. Ram, 1990, Targeted diagnosis and therapy.

Results of two Phase 1, Randomized, Double-blind, Placebo-controlled, Studies (Ascending Single-Dose and Multiple-Dose Studies) to Determine the Safety, Tolerability, and Pharmacokinetics of Orally Administered LX9211 in Healthy Participants.

Alan G. E. Wilson, S. Wason, P. Tyle, 2021, Clinical Therapeutics.

Penetration temperatures of aqueous sodium lauriminodipropionate solutions into solid phytosterols.

S. G. Frank, P. Tyle, 1991, Journal of pharmaceutical sciences.

PHYTOSTEROL STABILIZED EMULSIONS: CORRELATION BETWEEN RHEOLOGIC AND CALORIMETRIC STUDIES

S. G. Frank, P. Tyle, 1991 .

Degradation mechanism and kinetic studies of a novel anticancer agent, AG2034

C. Rowlings, J. S. Chu, P. Tyle, 1998 .

lontophoretic Devices for Drug Delivery

P. Tyle, 1986, Pharmaceutical Research.

Specialized drug delivery systems : manufacturing and production technology

P. Tyle, 1990 .